Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J G Hellstrom

Showing results (1-10 of 335) with videos related to

Pageof 34
Sort By:
Asian Journal of Andrology|September 7, 2010
Does erectile dysfunction drug use contribute to risky sexual behavior?Wayne J G Hellstrom
Thescientificworldjournal|September 7, 2004
Testosterone replacement therapyWayne J G Hellstrom
Current Urology Reports|November 19, 2003
Vardenafil: a new approach to the treatment of erectile dysfunctionWayne J G Hellstrom
International Journal of Impotence Research|June 17, 2008
Introduction: centrally acting agents in male sexual dysfunctionW J G Hellstrom
International Journal of Impotence Research|June 17, 2008
Clinical applications of centrally acting agents in male sexual dysfunctionW J G Hellstrom
Journal of Andrology|November 1, 2008
Medical management of Peyronie's diseaseWayne J G Hellstrom
Urology|July 23, 2015
Reply: To PMID 26199153Wayne J G Hellstrom
International Journal of Impotence Research|October 11, 2003
History, epidemiology, and clinical presentation of Peyronie's diseaseW J G Hellstrom
The Journal of the American Osteopathic Association|March 25, 2004
Benign prostatic hyperplasia, sexual function, and overall evaluation of the male patientWayne J G Hellstrom
International Journal of Clinical Practice|July 28, 2007
Current safety and tolerability issues in men with erectile dysfunction receiving PDE5 inhibitorsW J G Hellstrom
Pageof 34

Showing results (1-10 of 335) with videos related to

Sort By:
Pageof 34
Asian Journal of Andrology|September 7, 2010
Does erectile dysfunction drug use contribute to risky sexual behavior?Wayne J G Hellstrom
Thescientificworldjournal|September 7, 2004
Testosterone replacement therapyWayne J G Hellstrom
Current Urology Reports|November 19, 2003
Vardenafil: a new approach to the treatment of erectile dysfunctionWayne J G Hellstrom
International Journal of Impotence Research|June 17, 2008
Introduction: centrally acting agents in male sexual dysfunctionW J G Hellstrom
International Journal of Impotence Research|June 17, 2008
Clinical applications of centrally acting agents in male sexual dysfunctionW J G Hellstrom
Journal of Andrology|November 1, 2008
Medical management of Peyronie's diseaseWayne J G Hellstrom
Urology|July 23, 2015
Reply: To PMID 26199153Wayne J G Hellstrom
International Journal of Impotence Research|October 11, 2003
History, epidemiology, and clinical presentation of Peyronie's diseaseW J G Hellstrom
The Journal of the American Osteopathic Association|March 25, 2004
Benign prostatic hyperplasia, sexual function, and overall evaluation of the male patientWayne J G Hellstrom
International Journal of Clinical Practice|July 28, 2007
Current safety and tolerability issues in men with erectile dysfunction receiving PDE5 inhibitorsW J G Hellstrom
Pageof 34